CVRx (CVRX) Competitors $8.71 +0.83 (+10.53%) Closing price 10/3/2025 04:00 PM EasternExtended Trading$8.68 -0.03 (-0.34%) As of 10/3/2025 07:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CVRX vs. AXGN, CLPT, SIBN, BVS, AVNS, ZIMV, BFLY, KIDS, TMCI, and SMLRShould you be buying CVRx stock or one of its competitors? The main competitors of CVRx include AxoGen (AXGN), ClearPoint Neuro (CLPT), SiBone (SIBN), Bioventus (BVS), AVANOS MEDICAL (AVNS), ZimVie (ZIMV), Butterfly Network (BFLY), OrthoPediatrics (KIDS), Treace Medical Concepts (TMCI), and Semler Scientific (SMLR). These companies are all part of the "medical equipment" industry. CVRx vs. Its Competitors AxoGen ClearPoint Neuro SiBone Bioventus AVANOS MEDICAL ZimVie Butterfly Network OrthoPediatrics Treace Medical Concepts Semler Scientific CVRx (NASDAQ:CVRX) and AxoGen (NASDAQ:AXGN) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, valuation, analyst recommendations, profitability, media sentiment, earnings, dividends and institutional ownership. Which has more risk and volatility, CVRX or AXGN? CVRx has a beta of 1.26, indicating that its share price is 26% more volatile than the S&P 500. Comparatively, AxoGen has a beta of 1.04, indicating that its share price is 4% more volatile than the S&P 500. Do institutionals & insiders have more ownership in CVRX or AXGN? 75.3% of CVRx shares are owned by institutional investors. Comparatively, 80.3% of AxoGen shares are owned by institutional investors. 13.9% of CVRx shares are owned by insiders. Comparatively, 2.8% of AxoGen shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Which has stronger earnings and valuation, CVRX or AXGN? AxoGen has higher revenue and earnings than CVRx. AxoGen is trading at a lower price-to-earnings ratio than CVRx, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCVRx$51.29M4.44-$59.97M-$2.10-4.15AxoGen$187.34M4.39-$9.96M-$0.10-178.80 Does the media refer more to CVRX or AXGN? In the previous week, AxoGen had 22 more articles in the media than CVRx. MarketBeat recorded 22 mentions for AxoGen and 0 mentions for CVRx. AxoGen's average media sentiment score of 0.68 beat CVRx's score of 0.00 indicating that AxoGen is being referred to more favorably in the news media. Company Overall Sentiment CVRx Neutral AxoGen Positive Do analysts rate CVRX or AXGN? CVRx presently has a consensus target price of $14.00, indicating a potential upside of 60.73%. AxoGen has a consensus target price of $25.75, indicating a potential upside of 44.02%. Given CVRx's stronger consensus rating and higher possible upside, equities research analysts plainly believe CVRx is more favorable than AxoGen.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CVRx 2 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 2.63AxoGen 1 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.60 Is CVRX or AXGN more profitable? AxoGen has a net margin of -2.29% compared to CVRx's net margin of -95.61%. AxoGen's return on equity of -4.43% beat CVRx's return on equity.Company Net Margins Return on Equity Return on Assets CVRx-95.61% -79.31% -40.96% AxoGen -2.29%-4.43%-2.34% SummaryAxoGen beats CVRx on 9 of the 17 factors compared between the two stocks. Get CVRx News Delivered to You Automatically Sign up to receive the latest news and ratings for CVRX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CVRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CVRX vs. The Competition Export to ExcelMetricCVRxMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$227.78M$7.15B$6.13B$10.58BDividend YieldN/A1.16%5.65%4.69%P/E Ratio-4.1527.5386.9626.71Price / Sales4.44199.23604.82131.77Price / CashN/A22.0137.9061.31Price / Book2.975.3012.556.55Net Income-$59.97M$178.07M$3.31B$277.50M7 Day Performance15.36%5.15%4.28%2.42%1 Month Performance11.38%10.26%6.90%8.63%1 Year Performance-0.80%29.73%70.54%31.60% CVRx Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CVRXCVRx2.7433 of 5 stars$8.71+10.5%$14.00+60.7%-0.8%$227.78M$51.29M-4.15160High Trading VolumeAXGNAxoGen3.3095 of 5 stars$17.26+0.6%$26.00+50.6%+30.8%$789.58M$187.34M-172.58450Trending NewsAnalyst ForecastAnalyst RevisionCLPTClearPoint Neuro0.6797 of 5 stars$21.57+0.1%$19.67-8.8%+144.2%$612.61M$31.39M-26.63110News CoverageGap UpSIBNSiBone3.8965 of 5 stars$14.17+0.9%$23.67+67.0%-1.2%$606.13M$167.18M-25.30350Positive NewsBVSBioventusN/A$6.62-0.6%N/AN/A$550.64M$573.28M13.321,200AVNSAVANOS MEDICAL1.1736 of 5 stars$11.55-1.9%N/A-49.1%$546.16M$687.80M-1.152,227Positive NewsZIMVZimVie1.4441 of 5 stars$18.90-0.1%$17.75-6.1%+18.7%$533.47M$443.40M-27.001,770News CoveragePositive NewsShort Interest ↓BFLYButterfly Network3.231 of 5 stars$1.96-2.7%$3.00+53.5%+18.0%$506M$82.06M-6.98460KIDSOrthoPediatrics4.3982 of 5 stars$18.31+0.2%$34.14+86.5%-27.6%$458.35M$204.73M-10.23200Positive NewsTMCITreace Medical Concepts2.3601 of 5 stars$6.72+0.9%$9.83+46.3%+19.1%$420.73M$209.36M-8.51250SMLRSemler Scientific3.1895 of 5 stars$29.24+3.3%$74.25+153.9%+22.3%$419.12M$56.29M12.03120Trending News Related Companies and Tools Related Companies AXGN Competitors CLPT Competitors SIBN Competitors BVS Competitors AVNS Competitors ZIMV Competitors BFLY Competitors KIDS Competitors TMCI Competitors SMLR Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CVRX) was last updated on 10/5/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredU.S. Government Sparking Crypto RallyU.S. Puts GDP on the Blockchain Could this spark the next crypto supercycle? Discover the altcoins poised t...Crypto 101 Media | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredMelt-up warning Porter Stansberry says this bull market is past the “safe zone” and racing toward an event horizon — and in hi...Porter & Company | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredThe Coin That Could Define Trump’s Crypto PresidencyWhen Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top ad...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CVRx, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CVRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CVRX Stock Alerts